Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study (Q83768562)
Jump to navigation
Jump to search
scientific article published on 01 April 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study |
scientific article published on 01 April 2011 |
Statements
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study (English)
Frank G Holz
Winfried Amoaku
Ulrich Kellner
Reinier O Schlingemann
Andreas Weichselberger
SUSTAIN Study Group